References
- Kline R C, Swanson D P, Wieland D M, Thrall J H, Gross M D, Pitt B, Beierwaltes W H. Myocardial imaging in man with 1–123 metaiodobenzylguanidine. J Nucl Med 1981; 22: 129–132
- Merlet P, Valette H, Dubois‐Rande J, Moyse D, Duboc D, Dove P, Bourguignon M H, Benvenuti C, Duval A M, Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471–477
- Henderson E B, Kahn J K, Corbett J R, Jansen D E, Pippin J J, Kulkami P, Ugolini V, Akers M S, Hansen C, Buja L M. Abnormal 1–123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192–1199
- Stanton M S, Tuli M M, Radtke N Z, Heger J J, Miles W M, Mock B H, Burt R W, Wellman H N, Zipes D P. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 1–123 metaiodobenzylguanidine. J Am Cardiol 1989; 14: 1519–1526
- Glowniak J V, Turner F E, Gray L L, Palac R T, Lagunas‐Solar M C, Woodward W R. Iodine‐123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac‐transplants. J Nucl Med 1989; 30: 1182–1191
- Lekakis J, Prassopoulos V, Athanassiadis P, Kostamis P, Moulopoulos S. Doxorubicin‐induced cardiac neuro‐toxicity: Study with iodine 123‐labeled metaiodobenzylguanidine scintigraphy. J Nucl Cardiol 1996; 3: 37–41
- Langer A, Freeman M R, Jose R ‐G, Armstrong P W. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995; 25: 610–618
- Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fuji T, Yazaki Y, Isobe M, Sekiguchi M. Iodine ‐123‐metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1997; 29: 168–174
- Delahaye N, Dinanian S, Slama M S, Mzabi H, Samuel D, Merlet P, Le Gudulec D. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine‐123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999; 26: 416–424
- Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, Imamura H, Kinoshita O, Owa M, Fujii T. Iodine ‐123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 2002; 144: 122–129
- Reisinger J, Dubrey S W, Lavalley M, Skinner M, Falk R H. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol 1997; 30: 1046–1051
- Lerch H, Bartenstein P, Wichtez T, Hindricks G, Borggrefe M, Breithardt G, Schober O. Sympathetic innervation of the left ventricle is impaired in arrhythmogenic right ventricular dysplasia. Eur J Nucl Med 1993; 20: 207–212